| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sarcoidosis | 16 | 2023 | 38 | 5.050 |
Why?
|
| Genome-Wide Association Study | 15 | 2025 | 237 | 2.250 |
Why?
|
| HLA-DRB1 Chains | 5 | 2023 | 33 | 1.840 |
Why?
|
| African Americans | 13 | 2020 | 352 | 1.720 |
Why?
|
| Genetic Predisposition to Disease | 21 | 2025 | 676 | 1.600 |
Why?
|
| Polymorphism, Single Nucleotide | 19 | 2025 | 555 | 1.390 |
Why?
|
| Gene Frequency | 7 | 2022 | 185 | 1.310 |
Why?
|
| Sjogren's Syndrome | 11 | 2023 | 274 | 1.120 |
Why?
|
| Lupus Erythematosus, Systemic | 13 | 2018 | 994 | 1.070 |
Why?
|
| Software | 4 | 2021 | 127 | 0.930 |
Why?
|
| Transcriptome | 4 | 2025 | 231 | 0.910 |
Why?
|
| Central Nervous System Diseases | 1 | 2022 | 13 | 0.760 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2020 | 163 | 0.760 |
Why?
|
| Tuberculosis | 1 | 2022 | 25 | 0.740 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2022 | 33 | 0.730 |
Why?
|
| Single-Cell Analysis | 2 | 2020 | 56 | 0.680 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2020 | 60 | 0.660 |
Why?
|
| Genetics, Population | 3 | 2021 | 73 | 0.650 |
Why?
|
| Guanylate Kinases | 1 | 2020 | 2 | 0.650 |
Why?
|
| Humans | 51 | 2025 | 28884 | 0.650 |
Why?
|
| Eye Diseases | 1 | 2020 | 31 | 0.630 |
Why?
|
| Monocytes | 1 | 2020 | 135 | 0.620 |
Why?
|
| Cell Adhesion Molecules | 1 | 2020 | 69 | 0.620 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 465 | 0.570 |
Why?
|
| Alleles | 9 | 2023 | 354 | 0.570 |
Why?
|
| Genetic Loci | 3 | 2013 | 77 | 0.560 |
Why?
|
| Case-Control Studies | 11 | 2025 | 739 | 0.550 |
Why?
|
| Interferon-Induced Helicase, IFIH1 | 1 | 2017 | 11 | 0.520 |
Why?
|
| Chemokine CXCL10 | 1 | 2017 | 22 | 0.520 |
Why?
|
| Genotype | 7 | 2021 | 461 | 0.510 |
Why?
|
| Linkage Disequilibrium | 7 | 2021 | 108 | 0.490 |
Why?
|
| Nod2 Signaling Adaptor Protein | 1 | 2015 | 7 | 0.480 |
Why?
|
| Synovitis | 1 | 2015 | 6 | 0.480 |
Why?
|
| Arthritis | 1 | 2015 | 29 | 0.470 |
Why?
|
| Interleukin-6 | 1 | 2017 | 198 | 0.470 |
Why?
|
| Uveitis | 1 | 2015 | 23 | 0.460 |
Why?
|
| Haplotypes | 8 | 2018 | 284 | 0.440 |
Why?
|
| Male | 26 | 2025 | 13934 | 0.420 |
Why?
|
| Autoantibodies | 6 | 2025 | 481 | 0.400 |
Why?
|
| Female | 26 | 2025 | 15634 | 0.400 |
Why?
|
| Molecular Motor Proteins | 1 | 2011 | 13 | 0.370 |
Why?
|
| Apolipoproteins | 1 | 2011 | 21 | 0.360 |
Why?
|
| Myosin Heavy Chains | 1 | 2011 | 25 | 0.360 |
Why?
|
| Lipoproteins, HDL | 1 | 2011 | 41 | 0.360 |
Why?
|
| Adult | 15 | 2025 | 8030 | 0.350 |
Why?
|
| Lupus Nephritis | 1 | 2011 | 103 | 0.340 |
Why?
|
| Middle Aged | 15 | 2025 | 7416 | 0.340 |
Why?
|
| Quantitative Trait Loci | 4 | 2018 | 56 | 0.330 |
Why?
|
| Gene-Environment Interaction | 2 | 2020 | 13 | 0.320 |
Why?
|
| DNA-Binding Proteins | 5 | 2018 | 490 | 0.310 |
Why?
|
| Pedigree | 5 | 2019 | 155 | 0.310 |
Why?
|
| Epigenesis, Genetic | 2 | 2020 | 148 | 0.280 |
Why?
|
| Salivary Glands, Minor | 2 | 2017 | 21 | 0.270 |
Why?
|
| Mutation | 3 | 2017 | 867 | 0.270 |
Why?
|
| Autoimmune Diseases | 4 | 2018 | 166 | 0.260 |
Why?
|
| Models, Genetic | 5 | 2021 | 126 | 0.260 |
Why?
|
| Genetic Association Studies | 5 | 2018 | 115 | 0.250 |
Why?
|
| Immunity, Innate | 4 | 2018 | 231 | 0.250 |
Why?
|
| Family | 2 | 2019 | 99 | 0.250 |
Why?
|
| B-Lymphocytes | 3 | 2018 | 285 | 0.240 |
Why?
|
| Whole Genome Sequencing | 1 | 2025 | 25 | 0.240 |
Why?
|
| Bipolar Disorder | 1 | 2025 | 42 | 0.230 |
Why?
|
| Cardiac Myosins | 1 | 2025 | 18 | 0.230 |
Why?
|
| Myocarditis | 1 | 2025 | 21 | 0.230 |
Why?
|
| Schizophrenia | 1 | 2025 | 51 | 0.220 |
Why?
|
| Biomarkers | 4 | 2023 | 777 | 0.220 |
Why?
|
| Prognosis | 3 | 2022 | 811 | 0.220 |
Why?
|
| Telomere Homeostasis | 1 | 2024 | 11 | 0.220 |
Why?
|
| Heart Ventricles | 1 | 2025 | 139 | 0.220 |
Why?
|
| Telomere | 1 | 2024 | 36 | 0.210 |
Why?
|
| Myocardium | 1 | 2025 | 196 | 0.210 |
Why?
|
| Disease Progression | 3 | 2020 | 477 | 0.200 |
Why?
|
| Pulmonary Fibrosis | 1 | 2023 | 15 | 0.200 |
Why?
|
| Transcription Factors | 2 | 2018 | 523 | 0.200 |
Why?
|
| Interferon Regulatory Factors | 2 | 2014 | 58 | 0.200 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2023 | 20 | 0.190 |
Why?
|
| Severity of Illness Index | 4 | 2018 | 465 | 0.190 |
Why?
|
| Interleukin-17 | 2 | 2023 | 52 | 0.190 |
Why?
|
| Granuloma | 1 | 2022 | 18 | 0.190 |
Why?
|
| Aged | 9 | 2018 | 5599 | 0.190 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2023 | 60 | 0.190 |
Why?
|
| Membrane Proteins | 2 | 2018 | 485 | 0.180 |
Why?
|
| Antibodies, Antinuclear | 1 | 2023 | 183 | 0.180 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2014 | 285 | 0.180 |
Why?
|
| Clonal Anergy | 1 | 2020 | 11 | 0.170 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2023 | 138 | 0.170 |
Why?
|
| Organ Specificity | 1 | 2020 | 82 | 0.170 |
Why?
|
| Immunophenotyping | 1 | 2020 | 61 | 0.170 |
Why?
|
| Autoimmunity | 2 | 2020 | 158 | 0.160 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2020 | 84 | 0.160 |
Why?
|
| Morbidity | 1 | 2020 | 60 | 0.160 |
Why?
|
| United States | 4 | 2020 | 2225 | 0.160 |
Why?
|
| Gene Expression Regulation | 5 | 2024 | 634 | 0.150 |
Why?
|
| Cell Movement | 1 | 2020 | 376 | 0.150 |
Why?
|
| Algorithms | 3 | 2017 | 431 | 0.150 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2018 | 8 | 0.150 |
Why?
|
| Gene Expression | 1 | 2020 | 417 | 0.150 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2018 | 39 | 0.140 |
Why?
|
| Periodontitis | 1 | 2018 | 11 | 0.140 |
Why?
|
| Interferon-alpha | 1 | 2018 | 50 | 0.140 |
Why?
|
| Lupus Erythematosus, Discoid | 1 | 2018 | 18 | 0.140 |
Why?
|
| DNA | 1 | 2020 | 377 | 0.140 |
Why?
|
| Models, Biological | 1 | 2020 | 469 | 0.140 |
Why?
|
| STAT3 Transcription Factor | 1 | 2018 | 97 | 0.140 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2016 | 134 | 0.140 |
Why?
|
| Chromatin | 1 | 2018 | 76 | 0.140 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2018 | 112 | 0.140 |
Why?
|
| Up-Regulation | 1 | 2018 | 247 | 0.130 |
Why?
|
| Antibodies, Bacterial | 1 | 2018 | 103 | 0.130 |
Why?
|
| 2',5'-Oligoadenylate Synthetase | 1 | 2017 | 9 | 0.130 |
Why?
|
| Indians, North American | 2 | 2020 | 544 | 0.130 |
Why?
|
| Neutrophils | 1 | 2018 | 185 | 0.130 |
Why?
|
| Smoking | 2 | 2022 | 478 | 0.130 |
Why?
|
| Environmental Exposure | 1 | 2017 | 51 | 0.130 |
Why?
|
| Lymphoid Progenitor Cells | 1 | 2017 | 4 | 0.130 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 1032 | 0.130 |
Why?
|
| Genetic Drift | 1 | 2017 | 3 | 0.130 |
Why?
|
| Dendritic Cells | 1 | 2018 | 143 | 0.130 |
Why?
|
| Apoptosis | 1 | 2020 | 780 | 0.130 |
Why?
|
| Likelihood Functions | 1 | 2017 | 27 | 0.130 |
Why?
|
| Phenotype | 4 | 2022 | 686 | 0.130 |
Why?
|
| Interferon Type I | 1 | 2017 | 56 | 0.130 |
Why?
|
| Interferon-beta | 1 | 2017 | 40 | 0.130 |
Why?
|
| Thymus Gland | 1 | 2017 | 54 | 0.130 |
Why?
|
| Chromosome Mapping | 2 | 2014 | 128 | 0.130 |
Why?
|
| Biomedical Research | 1 | 2017 | 98 | 0.130 |
Why?
|
| Mice | 4 | 2023 | 4808 | 0.120 |
Why?
|
| Lymphocytes | 1 | 2017 | 90 | 0.120 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 2016 | 10 | 0.120 |
Why?
|
| Sex Chromosome Disorders of Sex Development | 1 | 2016 | 11 | 0.120 |
Why?
|
| Adaptive Immunity | 2 | 2013 | 38 | 0.120 |
Why?
|
| Animals | 6 | 2025 | 10699 | 0.120 |
Why?
|
| Neoplasm Proteins | 2 | 2014 | 123 | 0.120 |
Why?
|
| Adipose Tissue | 1 | 2017 | 197 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 251 | 0.120 |
Why?
|
| Sarcoidosis, Pulmonary | 1 | 2015 | 2 | 0.120 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 169 | 0.120 |
Why?
|
| Risk Factors | 5 | 2020 | 2127 | 0.110 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2014 | 12 | 0.110 |
Why?
|
| beta Karyopherins | 1 | 2014 | 13 | 0.110 |
Why?
|
| Databases as Topic | 1 | 2014 | 22 | 0.110 |
Why?
|
| HLA-DP beta-Chains | 1 | 2014 | 1 | 0.110 |
Why?
|
| HLA-DQ beta-Chains | 1 | 2014 | 14 | 0.110 |
Why?
|
| Osteoarthropathy, Primary Hypertrophic | 1 | 2014 | 1 | 0.110 |
Why?
|
| Genotyping Techniques | 1 | 2014 | 21 | 0.110 |
Why?
|
| Information Dissemination | 1 | 2014 | 37 | 0.110 |
Why?
|
| Organic Anion Transporters | 1 | 2014 | 8 | 0.110 |
Why?
|
| Carrier Proteins | 1 | 2016 | 255 | 0.110 |
Why?
|
| Cell Differentiation | 1 | 2017 | 427 | 0.110 |
Why?
|
| Drug Resistance | 1 | 2014 | 42 | 0.110 |
Why?
|
| Signal Transduction | 1 | 2020 | 1469 | 0.100 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 78 | 0.100 |
Why?
|
| Epistasis, Genetic | 1 | 2013 | 24 | 0.100 |
Why?
|
| Gene Regulatory Networks | 1 | 2013 | 82 | 0.100 |
Why?
|
| Colonic Neoplasms | 1 | 2014 | 122 | 0.100 |
Why?
|
| Major Histocompatibility Complex | 1 | 2012 | 28 | 0.100 |
Why?
|
| Biopsy | 3 | 2017 | 208 | 0.090 |
Why?
|
| Databases, Genetic | 1 | 2012 | 49 | 0.090 |
Why?
|
| Meta-Analysis as Topic | 1 | 2012 | 33 | 0.090 |
Why?
|
| Ikaros Transcription Factor | 1 | 2012 | 9 | 0.090 |
Why?
|
| Egg Proteins | 1 | 2012 | 17 | 0.090 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2012 | 15 | 0.090 |
Why?
|
| Cohort Studies | 4 | 2018 | 897 | 0.090 |
Why?
|
| Apolipoprotein L1 | 1 | 2011 | 10 | 0.090 |
Why?
|
| Disease | 1 | 2012 | 15 | 0.090 |
Why?
|
| Fibrosis | 2 | 2025 | 143 | 0.090 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 2010 | 19 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2010 | 34 | 0.080 |
Why?
|
| Hyaluronan Receptors | 1 | 2010 | 31 | 0.080 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 787 | 0.080 |
Why?
|
| Aging | 1 | 2017 | 1017 | 0.080 |
Why?
|
| Cross-Sectional Studies | 3 | 2020 | 995 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 249 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 3 | 2014 | 377 | 0.070 |
Why?
|
| Cytokines | 2 | 2023 | 451 | 0.060 |
Why?
|
| Genomics | 2 | 2020 | 125 | 0.060 |
Why?
|
| Consensus | 2 | 2017 | 76 | 0.060 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2025 | 24 | 0.060 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2025 | 20 | 0.060 |
Why?
|
| Cross Reactions | 1 | 2025 | 74 | 0.060 |
Why?
|
| Logistic Models | 2 | 2017 | 410 | 0.060 |
Why?
|
| Flow Cytometry | 2 | 2017 | 292 | 0.060 |
Why?
|
| Europe | 2 | 2015 | 99 | 0.050 |
Why?
|
| K562 Cells | 1 | 2024 | 20 | 0.050 |
Why?
|
| Genetic Markers | 2 | 2015 | 92 | 0.050 |
Why?
|
| Epitopes | 1 | 2025 | 185 | 0.050 |
Why?
|
| Exome | 2 | 2014 | 32 | 0.050 |
Why?
|
| CRISPR-Cas Systems | 1 | 2024 | 51 | 0.050 |
Why?
|
| Dysbiosis | 1 | 2023 | 15 | 0.050 |
Why?
|
| Vimentin | 1 | 2023 | 28 | 0.050 |
Why?
|
| Estrogens | 1 | 2023 | 56 | 0.050 |
Why?
|
| Genetic Variation | 2 | 2014 | 246 | 0.050 |
Why?
|
| Whole Exome Sequencing | 1 | 2020 | 9 | 0.040 |
Why?
|
| Epigenomics | 1 | 2020 | 28 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2020 | 58 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2021 | 128 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 118 | 0.040 |
Why?
|
| Precision Medicine | 1 | 2020 | 82 | 0.040 |
Why?
|
| Bleomycin | 1 | 2018 | 11 | 0.040 |
Why?
|
| Collagen Type I | 1 | 2018 | 27 | 0.040 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 1 | 2018 | 7 | 0.040 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2018 | 14 | 0.040 |
Why?
|
| Treponema denticola | 1 | 2018 | 6 | 0.040 |
Why?
|
| Porphyromonas gingivalis | 1 | 2018 | 7 | 0.040 |
Why?
|
| Introns | 1 | 2018 | 43 | 0.040 |
Why?
|
| Th17 Cells | 1 | 2018 | 33 | 0.040 |
Why?
|
| Genetic Linkage | 1 | 2018 | 95 | 0.040 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2017 | 8 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2019 | 232 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2018 | 160 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2017 | 95 | 0.030 |
Why?
|
| Binding Sites | 1 | 2018 | 355 | 0.030 |
Why?
|
| ROC Curve | 1 | 2017 | 144 | 0.030 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2017 | 7 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2017 | 48 | 0.030 |
Why?
|
| Virus Diseases | 1 | 2017 | 39 | 0.030 |
Why?
|
| Linear Models | 1 | 2017 | 202 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2017 | 58 | 0.030 |
Why?
|
| Cell Separation | 1 | 2017 | 57 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2017 | 53 | 0.030 |
Why?
|
| Oklahoma | 1 | 2020 | 1053 | 0.030 |
Why?
|
| Young Adult | 2 | 2014 | 2839 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2017 | 202 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 237 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2016 | 35 | 0.030 |
Why?
|
| Sex Chromosome Aberrations | 1 | 2016 | 16 | 0.030 |
Why?
|
| Trisomy | 1 | 2016 | 19 | 0.030 |
Why?
|
| Hypergammaglobulinemia | 1 | 2016 | 7 | 0.030 |
Why?
|
| Tripartite Motif Proteins | 1 | 2016 | 8 | 0.030 |
Why?
|
| Sulfur Radioisotopes | 1 | 2016 | 10 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2016 | 78 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 485 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2018 | 668 | 0.030 |
Why?
|
| Rheumatoid Factor | 1 | 2016 | 28 | 0.030 |
Why?
|
| Chromosomes, Human, X | 1 | 2016 | 38 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2016 | 75 | 0.030 |
Why?
|
| Methionine | 1 | 2016 | 38 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2016 | 68 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2016 | 72 | 0.030 |
Why?
|
| Age Factors | 1 | 2017 | 737 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 513 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2018 | 825 | 0.030 |
Why?
|
| Ribonucleoproteins | 1 | 2016 | 154 | 0.030 |
Why?
|
| Immunoglobulins | 1 | 2014 | 34 | 0.030 |
Why?
|
| Prevalence | 1 | 2016 | 518 | 0.030 |
Why?
|
| Least-Squares Analysis | 1 | 2014 | 17 | 0.030 |
Why?
|
| Prostaglandins | 1 | 2014 | 13 | 0.030 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2014 | 3 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2014 | 102 | 0.030 |
Why?
|
| Informed Consent | 1 | 2014 | 26 | 0.030 |
Why?
|
| Heterozygote | 1 | 2014 | 69 | 0.030 |
Why?
|
| Dinoprostone | 1 | 2014 | 42 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2014 | 33 | 0.030 |
Why?
|
| Attitude | 1 | 2014 | 44 | 0.030 |
Why?
|
| Perception | 1 | 2014 | 90 | 0.030 |
Why?
|
| Environment | 1 | 2014 | 66 | 0.030 |
Why?
|
| HLA-DR beta-Chains | 1 | 2013 | 2 | 0.030 |
Why?
|
| Radiography | 1 | 2014 | 203 | 0.030 |
Why?
|
| Sialyltransferases | 1 | 2013 | 5 | 0.030 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2013 | 61 | 0.030 |
Why?
|
| NADPH Oxidases | 1 | 2013 | 69 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 1508 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 344 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2012 | 42 | 0.020 |
Why?
|
| Computational Biology | 1 | 2014 | 156 | 0.020 |
Why?
|
| Asian Americans | 1 | 2012 | 40 | 0.020 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2011 | 15 | 0.020 |
Why?
|
| Genome, Human | 1 | 2012 | 70 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 1658 | 0.020 |
Why?
|
| Risk | 1 | 2011 | 138 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2011 | 39 | 0.020 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2011 | 24 | 0.020 |
Why?
|
| American Native Continental Ancestry Group | 1 | 2010 | 22 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2014 | 1002 | 0.020 |
Why?
|
| Base Sequence | 1 | 2011 | 589 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2011 | 1056 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 2065 | 0.020 |
Why?
|
| Adolescent | 1 | 2013 | 3197 | 0.010 |
Why?
|